News

Avella Newsroom

January 1, 1970|
NCPDP Annual Conference Keynote Panel to Address “Data Challenges and Opportunities to Improve the Patient Journey”
April 17, 2018| CATEGORIES: Avella , Specialty Pharmacy , Press Mention

NCPDP announced today the Opening Keynote Panel for its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey, May 7-9, 2018, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. The Keynote Panel will address “Data Challenges and Opportunities to Improve the Patient Journey,” on Tuesday, May 8, 2018. Avella founder and chairman of the board, John Musil, will participate on the panel representing specialty pharmacy.

LD Networks Shrinking; What Do You Need to Get In?
April 2, 2018| CATEGORIES: Specialty Pharmacy , Press Feature , limited distribution drugs

Many of today’s most effective specialty drugs are distributed through limited networks of specialty pharmacies, ranging in size from exclusive (one to two pharmacies) through limited small (two to five pharmacies) and limited large (six to 15 pharmacies). A new white paper from Avella Specialty Pharmacy reports that with 79.2% of manufacturers managing their specialty products through a limited distribution (LD) model, these LDs are shrinking even more, consisting of fewer pharmacies than they did just a decade ago.

The Leukemia & Lymphoma Society (LLS) Names Avella Executive Hamilton Baiden as the Corporate Walk Chair for Greater Phoenix Light The Night
March 29, 2018| CATEGORIES: Avella , Oncology , LLS , Press Release

Phoenix, AZ – The Arizona Chapter of The Leukemia & Lymphoma Society (LLS) announced today that Avella Specialty Pharmacy Executive Vice President Hamilton Baiden will serve as the Corporate Walk Chair of the 2018 Greater Phoenix Light The Night.

Improving medication adherence — something’s got to give
January 25, 2018| CATEGORIES: Adherence , Press Mention

Avella was recently featured in Pharmaceutical Commerce article for its work in medication adherence and technology. 

Poor adherence to prescribed medications creates one of today’s most pressing public health issues. When patients fail to take their medications as prescribed — either stopping before the course of treatment is complete, abandoning long-term therapies prescribed for chronic conditions, or taking the medications incorrectly — it creates far-reaching clinical and financial consequences for all stakeholders:

Abby Kaplan is Avella Specialty Pharmacy's Master of Acquisition
December 26, 2017| CATEGORIES: Avella , Press Feature

There are two main ways to expand a company,” says Avella Specialty Pharmacy’s Abby Kaplan. “You can do it organically, or you can do it through acquisition.” In 2016, Avella did both.

Controversy Heats Up Over Pharmacy Benefit Manager DIR fees
November 10, 2017| CATEGORIES: Press Mention , DIR Fees

Pharmacy benefits managers (PBMs) are in hot water again if small and specialty pharmacies’ voices can be heard. Besides a litany of complaints from various pharmacy industry stakeholders about PBM operations and business tactics—from a lack of transparency to controlling formularies—now PBMs are being accused of retroactively applying direct and indirect remuneration fees (DIR) to pharmacies.

Smart Pill Bottles Among New Technologies Emerging to Boost Patient Outcomes
November 7, 2017| CATEGORIES: Adherence , Press Mention

Through emerging options that create automated processes to address prevention and wellness and increase accountability by the patient, specialty pharmacy has the ability to deliver greater value, said Eric Sredzinski, executive vice-president of clinical affairs and quality assurance with Avella Specialty Pharmacy.

Avella Is Now the Third Largest Privately-Held Company in the State According to the Arizona Corporate Excellence (ACE) Awards.
November 3, 2017| CATEGORIES: Avella , ACE Awards , Press Release

Phoenix, AZ -- Avella Specialty Pharmacy announced that it has been named the third largest privately-held company in the state by the Phoenix Business Journal through its Arizona Corporate Excellence (ACE) Awards. Avella moved up from its rank as the fourth largest in 2016 and was also recognized as the sixth fastest-growing company in Arizona this year.

Avella Selected by AstraZeneca to Distribute CALQUENCE® (acalabrutinib)
October 31, 2017| CATEGORIES: Oncology , Press Release

The specialty pharmacy will provide access to this FDA-approved, second-generation treatment for mantle cell lymphoma

Avella's Take on Diabetic Macular Edema
October 26, 2017| CATEGORIES: ophthalmology , Press Mention

Avella's Vice President of Ophthalmology, Jim Rehovsky, is featured in Specialty Pharmacy Continuum article titled, Diabetic Macular Edema: 6 Steps for Better Control.

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe
Featured Video
Photo of Brian Halligan
Path of a Specialty Prescription
The path of a specialty prescription is complex. This video details each step of the path and the unique offerings of Avella.
Media Contact

Sarah McLeod
800-516-2881  x103
smcleod@activate-health.com

Avella is available to coordinate subject matter expert interviews on a variety of topics including.

  • Specialty pharmacy/pharmacist role
  • Medication adherence and technology
  • Specialty pharmacy pricing considerations

Please contact Sarah McLeod for more information about Avella Specialty Pharmacy.

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe